Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    15 December 2022

    Global Access Diagnostics joins consortium to co-develop on-farm rapid test for calf pneumonia, RaDiCal

    Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced the development of RaDiCal, a one-step molecular lateral flow test to enable rapid diagnosis of pneumonia, one of the most significant dise...

    14 December 2022

    PhoreMost and ThinkCyte collaborate to advance AI based drug discovery

    PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, today announced a strategic research partnership aimed at advancing modern ...

    13 December 2022

    Sphere Fluidics appoints Richard Hammond as Chief Technical Officer

    Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion of microfluidic product range for single cell analysis ...

    13 December 2022

    Salus Wellness welcomes Emily Woollins to the team

    Emily is an experienced Nutritional Therapist specializing in supporting clients with IBS (Irritable Bowel Syndrome) and other digestive disorders. She regularly works with clients suffering with pain, bloating, fatigue and suspected food intolerances. ...

    12 December 2022

    Guardtech Group December Wrap-Up: a year of huge growth, joy and goodwill to all

    As 2022 comes to a close, cleanroom construction specialists Guardtech joyously celebrate their busiest ever year. ...

    9 December 2022

    Cambridge & Huntingdon based property firm Rapleys makes biggest acquisition in 72 years

    London, UK - Rapleys announces it has welcomed London surveying firm Aston Rose into its business, the biggest single expansion in the partnership's 72 year history. The property consultancy has been on a strategic growth drive in recent months having onboarded planning practice CSJ in ...

    5 December 2022

    Anne Glover and Hermann Hauser, reflecting on 25 years of Amadeus Capital Partners

    As Amadeus celebrates 25 years since it was founded, Partner Amelia Armour sits down with Hermann Hauser and Anne Glover to reflect on the past three decades in our latest podcast episode. ...

    8 December 2022

    The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

    Antigen designed to support immunoassay and vaccine development applications

    7 December 2022

    Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics

    NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency ...

    7 December 2022

    Metrion Biosciences and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder

    Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 217
    • Page 218
    • Current page 219
    • Page 220
    • Page 221
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS